Immunotherapy Patient Summit

Jedd D. Wolchok, M.D., Ph.D., associate director of CRI's Scientific Advisory Council treated Mary Elizabeth Williams with immunotherapy for stage 4 melanoma in 2011. Harnessing the immune system to fight cancer has…

On Friday, the FDA announced its approval of pembrolizumab (Keytruda®) to treat recurrent or metastatic head and neck cancer that has failed to respond to chemotherapy. The drug, which targets the PD-1 molecule found…

We’re just over a month away from the first Cancer Research Institute Immunotherapy Patient Summit and we’ve been blown away by the response to the event. The response has been so positive, we’ve had to increase…